167 related articles for article (PubMed ID: 20339552)
1. A camelid anti-PrP antibody abrogates PrP replication in prion-permissive neuroblastoma cell lines.
Jones DR; Taylor WA; Bate C; David M; Tayebi M
PLoS One; 2010 Mar; 5(3):e9804. PubMed ID: 20339552
[TBL] [Abstract][Full Text] [Related]
2. PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein.
Tayebi M; Taylor WA; Jones DR; Bate C; David M
J Gen Virol; 2010 Aug; 91(Pt 8):2121-2131. PubMed ID: 20375226
[TBL] [Abstract][Full Text] [Related]
3. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
Enari M; Flechsig E; Weissmann C
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893
[TBL] [Abstract][Full Text] [Related]
4. Development of antibody fragments for immunotherapy of prion diseases.
Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
[TBL] [Abstract][Full Text] [Related]
5. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
[TBL] [Abstract][Full Text] [Related]
6. Potential candidate camelid antibodies for the treatment of protein-misfolding diseases.
David MA; Jones DR; Tayebi M
J Neuroimmunol; 2014 Jul; 272(1-2):76-85. PubMed ID: 24864011
[TBL] [Abstract][Full Text] [Related]
7. PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers.
Tayebi M; Jones DR; Taylor WA; Stileman BF; Chapman C; Zhao D; David M
PLoS One; 2011; 6(5):e19998. PubMed ID: 21625515
[TBL] [Abstract][Full Text] [Related]
8. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
Pankiewicz J; Prelli F; Sy MS; Kascsak RJ; Kascsak RB; Spinner DS; Carp RI; Meeker HC; Sadowski M; Wisniewski T
Eur J Neurosci; 2006 May; 23(10):2635-47. PubMed ID: 16817866
[TBL] [Abstract][Full Text] [Related]
9. PrPSc binding antibodies are potent inhibitors of prion replication in cell lines.
Beringue V; Vilette D; Mallinson G; Archer F; Kaisar M; Tayebi M; Jackson GS; Clarke AR; Laude H; Collinge J; Hawke S
J Biol Chem; 2004 Sep; 279(38):39671-6. PubMed ID: 15133046
[TBL] [Abstract][Full Text] [Related]
10. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
Perrier V; Solassol J; Crozet C; Frobert Y; Mourton-Gilles C; Grassi J; Lehmann S
J Neurochem; 2004 Apr; 89(2):454-63. PubMed ID: 15056288
[TBL] [Abstract][Full Text] [Related]
11. Characterization of prion susceptibility in Neuro2a mouse neuroblastoma cell subclones.
Uryu M; Karino A; Kamihara Y; Horiuchi M
Microbiol Immunol; 2007; 51(7):661-9. PubMed ID: 17641468
[TBL] [Abstract][Full Text] [Related]
12. Generation of antibodies against prion protein by scrapie-infected cell immunization of PrP(0/0) mice.
Nakamura N; Miyamoto K; Shimokawa M; Nishida N; Mohri S; Kitamoto T; Horiuchi H; Furusawa S; Matsuda H
Hybrid Hybridomics; 2003 Aug; 22(4):263-6. PubMed ID: 14511572
[TBL] [Abstract][Full Text] [Related]
13. Anti-PrP antibodies detected at terminal stage of prion-affected mouse.
Sassa Y; Kataoka N; Inoshima Y; Ishiguro N
Cell Immunol; 2010; 263(2):212-8. PubMed ID: 20417929
[TBL] [Abstract][Full Text] [Related]
14. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP
Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM
J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306
[TBL] [Abstract][Full Text] [Related]
15. Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains.
Korth C; Kaneko K; Prusiner SB
J Gen Virol; 2000 Oct; 81(Pt 10):2555-2563. PubMed ID: 10993946
[TBL] [Abstract][Full Text] [Related]
16. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
17. Attempts to convert the cellular prion protein into the scrapie isoform in cell-free systems.
Raeber AJ; Borchelt DR; Scott M; Prusiner SB
J Virol; 1992 Oct; 66(10):6155-63. PubMed ID: 1356161
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery.
Yun SW; Ertmer A; Flechsig E; Gilch S; Riederer P; Gerlach M; Schätzl HM; Klein MA
J Neurovirol; 2007 Aug; 13(4):328-37. PubMed ID: 17849316
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.
Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
